From: An economic model of long-term use of celecoxib in patients with osteoarthritis
Simple health states | QALY losses | Reference |
---|---|---|
Dyspepsia (-0.13) | ||
Resolved events (35 days) | -0.01247 (-0.005753 to -0.01496) | [38] |
Chronic per year | -0.13 (-0.06 to -0.156) | [38] |
Symptomatic peptic ulcers (-0.13) | ||
Resolved events (35 days) | -0.01247 (-0.005753 to -0.01496) | [38] |
Chronic per year | -0.13 (-0.06 to -0.156) | [38] |
Hospitalization stays | ||
POB (ALOS = 5.56 days) | -0.007926 (-0.00634 to -0.009511) | [12,40,41] |
Peptic ulcers (ALOS = 4.10 days) | -0.005868 (-0.004694 to -0.007042) | [12,40,41] |
Outpatient POB ER visit | -0.001397 (-0.001118 to -0.001676) | [41] |
Endoscopy (-0.4325) | -0.00119 (-000952 to -0.001428) | [41] |
Premature POB death per year | -0.67 (-0.536 to -0.804) | [36,37] |